LLYX logo

LLYXDefiance Daily Target 2X Long LLY ETF

$25.20
$1.26
(4.80%)
Today
Closed $24.99
$0.21
(0.84%)
Overnight
Updated: 08:32 PM EDT
Vol341,169.00
52W High$28.44
52W Low$9.60
News
all
press releases
News Placeholder
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Fourth-quarter revenue surged 43% to $19.3 billion, above Street estimates of $17.86 billion, according to Fiscal.ai data.
Stocktwits
News Placeholder
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits
<
...
1
>

Advertisement|Remove ads.